APA

Cagnard B., Tosoni-Verlingue D., Tribut O., Moizard C., Bridoux-Henno L., Delaperriere N., Bentue-Ferrer D. & Dabadie A. (20070731). [Advantages of different dosages of active metabolites in the follow-up of azathioprine treatment for Crohn disease]. : Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Chicago

Cagnard B, Tosoni-Verlingue D, Tribut O, Moizard C, Bridoux-Henno L, Delaperriere N, Bentue-Ferrer D and Dabadie A. 20070731. [Advantages of different dosages of active metabolites in the follow-up of azathioprine treatment for Crohn disease]. : Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Harvard

Cagnard B., Tosoni-Verlingue D., Tribut O., Moizard C., Bridoux-Henno L., Delaperriere N., Bentue-Ferrer D. and Dabadie A. (20070731). [Advantages of different dosages of active metabolites in the follow-up of azathioprine treatment for Crohn disease]. : Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

MLA

Cagnard B, Tosoni-Verlingue D, Tribut O, Moizard C, Bridoux-Henno L, Delaperriere N, Bentue-Ferrer D and Dabadie A. [Advantages of different dosages of active metabolites in the follow-up of azathioprine treatment for Crohn disease]. : Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. 20070731.